Inactive Instrument
PhaseRx Inc Stock Nasdaq
Stocks
US71723F1030
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.56M 3.99M 3.68M 3.4M 6.45M 435M 6.55M 43.95M 17.26M 214M 17.12M 16.75M 736M | P/E 2015 * |
-
| P/E 2016 | -0.58x |
|---|---|---|---|---|---|
| Enterprise Value | -5.22M -4.56M -4.21M -3.89M -7.38M -498M -7.5M -50.29M -19.75M -245M -19.59M -19.16M -843M | EV / Sales 2015 * |
-
| EV / Sales 2016 | - |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -77.95% | - | - | 11 | |
| -4.14% | -8.06% | +57.35% | +117.24% | 54.63B | |
| +1.84% | -0.66% | +75.79% | +93.87% | 54.88B | |
| -2.24% | +3.59% | +19.60% | +466.72% | 25.06B | |
| -1.60% | -6.21% | -19.69% | -14.84% | 23.14B | |
| +2.43% | +1.06% | +47.70% | -0.11% | 19.88B | |
| -3.19% | 0.00% | +33.99% | -26.87% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +357.18% | 16.5B | |
| -1.05% | +1.16% | +25.08% | +196.28% | 14.2B | |
| +8.74% | +3.51% | +53.81% | - | 15.36B | |
| Average | -0.61% | -0.28% | +54.31% | +148.68% | 26.8B | |
| Weighted average by Cap. | -0.91% | -1.46% | +55.04% | +137.79% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 375K 328K 303K 279K 530K 35.77M 539K 3.61M 1.42M 17.62M 1.41M 1.38M 60.57M | - |
| Net income | -7.38M -6.45M -5.95M -5.5M -10.43M -704M -10.61M -71.11M -27.93M -347M -27.7M -27.1M -1.19B | -20.14M -17.61M -16.25M -15.01M -28.47M -1.92B -28.95M -194M -76.23M -946M -75.61M -73.96M -3.25B |
| Net Debt | 16.55M 14.48M 13.35M 12.33M 23.4M 1.58B 23.8M 160M 62.66M 778M 62.14M 60.79M 2.67B | -9.78M -8.55M -7.89M -7.28M -13.82M -932M -14.05M -94.24M -37.01M -459M -36.71M -35.91M -1.58B |
Employees
-
Choose MarketScreener 
